Exacerbation of hepatitis B infection following cessation of lamivudine therapy.
Barlow
G D
GD
France
A J
AJ
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D012008:Recurrence
D019380:Anti-HIV Agents; D019259:Lamivudine